Light Sciences Oncology
Latest round
- Series B
Last raised
- Jul 2007
Total raised
- $62M
Investors
- 14
About Light Sciences Oncology
Founded in 1994 and based in Washington, US, Light Sciences Oncology Inc. develops light-activated drug products to treat patients with solid tumor cancers as well as benign prostatic hyperplasia (BPH). The company offers Aptocine, a water-soluble drug design to provide treatments for patients with hepatocellular carcinoma (HCC) and metastatic colorectal cancer (MCRC).
Who invested in Light Sciences Oncology
14 investors across 3 rounds
See all investors in Light Sciences Oncology
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Light Sciences Oncology
Who invested in Light Sciences Oncology?
Light Sciences Oncology has 14 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Light Sciences Oncology raised?
Light Sciences Oncology has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Light Sciences Oncology last raise money?
Light Sciences Oncology's most recent round on record is a Series B, in Jul 2007.
What does Light Sciences Oncology do?
Founded in 1994 and based in Washington, US, Light Sciences Oncology Inc.
Where is Light Sciences Oncology headquartered?
Light Sciences Oncology is headquartered in Bellevue, US.
Which VCs invest in companies like Light Sciences Oncology?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Light Sciences Oncology's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Light Sciences Oncology? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.